[May 03, 2011] Stereotaxis Launches New Stereotaxis Epoch Platform Tweet May 03, 2011 (Close-Up Media via COMTEX) -- Stereotaxis, Inc. announced the introduction of its new Stereotaxis Epoch platform, a solution for any electrophysiology lab which combines the recognized benefits of remote magnetic catheter control, the efficiency of remote robotic device manipulation, and the power of the Odyssey platform, enabling procedural data integration and transmission. According to a release, the Epoch platform will be unveiled at the annual Heart Rhythm Society meeting May 5-7, in San Francisco, CA. The Stereotaxis Epoch solution is the beginning of a new modular platform designed to meet the broad range of clinical needs physicians face today and in the future. Building on the strength of Magnetic Navigation's exceptional safety profile and significant radiation reduction, the Epoch platform features the latest technological breakthroughs in Magnetic Navigation, which will lead to faster, more efficient, and dynamic magnetic catheter control. In addition, the Epoch platform will seamlessly integrate Stereotaxis' Vdrive mechanical robotic platform for remote manipulation of a growing array of devices, such as loop diagnostic catheter and sheath. The company noted that the Epoch solution delivers value well beyond the lab with the power of Stereotaxis' Odyssey solutionan offering which integrates the complex array of clinical data into synchronized, high-definition view delivering real-time clinical information anywhere at physicians' fingertips. The Odyssey solution enables hospital executives to drive initiatives which improve care, enhance performance, and increase referrals and market services throughout global communities. "We are excited to introduce our Epoch solutions to the EP market as we are committed to developing solutions that meet the most critical needs of our customers, while supporting any preferred clinical treatment technique," said Michael P. Kaminski, President and CEO of Stereotaxis. "Early feedback from key opinion leaders suggests that the Epoch platform enables us to deliver a much more efficient and enhanced EP workflow while maintaining our excellent profile in safety, radiation reduction and clinical outcome." Stereotaxis reported that it expects that the Stereotaxis Epoch solutions will significantly reduce procedure time for all types of robotic-assisted EP procedures, especially for atrial fibrillation ablation procedures. In addition, user learning curve will be accelerated as a result of automated scripting of expert users' navigation techniques. Furthermore, labs equipped with the Vdrive module can benefit from optimized and full remote navigation and control of devices such as loop diagnostic catheters and sheaths. Stereotaxis designs, manufactures and markets a cardiology instrument control system for use in a hospital's interventional surgical suite to enhance the treatment of coronary artery disease and arrhythmias. More Information: stereotaxis.com ((Comments on this story may be sent to [email protected])) [ Back To TMCnet.com's Homepage ]